Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence.

Ther Adv Gastroenterol · 2020 · PMC7288799 · PMID 32565912

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Highly significant decreases in the mean number of eosinophils (eosinophilic load) ( Table 4 ), and the mean peak number of eosinophils were observed for all three budesonide groups in all segments of the esophagus.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.